Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects

Обложка

Цитировать

Полный текст

Аннотация

The HIV-1 integrase enzyme is responsible for one of the key stages of retroviral replication; it acts as a catalyst for the integration of viral cDNA into the cell’s genome. Inhibitors of HIV-1 integration have been under development for over 10 years; yet, only one integration inhibitor, raltegravir, has been approved for clinical use so far. Raltegravir binds two metal ions in the enzyme’s active centre and blocks one of the integration stages: the strand transfer. Unfortunately, the clinical use of raltegravir results in the development of viral resistance among some patients. Several more HIV-1 integration inhibitors are undergoing clinical trials at the moment. However, the structure and mechanism of action of those are similar to raltegravir, which results in the emergence of cross resistance with raltegravir. The present review is focused on the history of the development and clinical trials of raltegravir and its analogues, the problems connected with the emergence of viral resistance to integration inhibitors, and the prospect of their future clinical use.

Полный текст

Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects
×

Список литературы

  1. http://www.unaids.org/ru
  2. Simon V., Ho D.D., Abdool Karim Q. // Lancet. 2006. V. 368. № 9534. P. 489-504.
  3. Turner B.G., Summers M.F. // J. Mol. Biol. 1999. V. 285. P. 1-32.
  4. Miller M.D., Farnet C.M., Bushman F.D. // J. Virol. 1997. V. 71. P 5382-5390.
  5. Piller S.C., Caly L., Jans D.A. // Cur. Drug. Targets. 2003. V. 4. № 5. P 409-429.
  6. Li L., Olvera J., Yoder K., Mitchell R.S., Butler S.L., Lieber M., Martin S.L., Bushman F.D. // EMBO J. 2001. V. 20. P. 3272-3281.
  7. Farnet C.M., Bushman F.D. // Cell. 1997. V. 88. P 483-492.
  8. Lin C.W., Engelman A. // J. Virol. 2003. V. 77. P 5030-5036.
  9. Vandegraaff N., Devroe E., Turlure F., Silver P.A., Engelman A. // Virology. 2006. V. 346. P 415-426.
  10. Marcelin A.G., Ceccherini-Silberstein F., Perno C.F., Calvez V. // Curr. Opin. HIV AIDS. 2009. V. 4. № 6. P. 531-537.
  11. FDA approves raltegravir tablets // AIDS Patient Care STDS. 2007. V. 21. № 11. P. 889.
  12. Cara A., Guarnaccia F., Reitz M.S. Jr., Gallo R.C., Lori F. // Virology. 1995. V. 208. P. 242-248.
  13. Ramkumar K., Serrao E., Odde S., Neamati N. // Med. Res. Rev. 2010. V. 30. № 5. P. 750-814.
  14. Mouscadet J.F., Delelis O., Marcelin A.G., Tchertanov L. // Drug Resist Updat. 2010. V. 13. № 4-5. P. 139-150.
  15. De Clercq E. // Curr. Opin. Pharmacol. 2010. V. 10. № 5. P. 507-515.
  16. Al-Mawsawi L.Q., Al-Safi R.I., Neamati N. // Expert Opin. Emerg. Drugs. 2008. V. 13. № 2. P 213-225.
  17. Gatell J.M. // Eur. J. Med. Res. 2009. V. 14. P. 30-35.
  18. Serrao E., Odde S., Ramkumar K., Neamati N. // Retrovirology. 2009. V. 6. № 25. Р
  19. Prikazchikova T.A., Sycheva A.M., Agapkina Yu.Yu., Aleksandrov D.A., Gottikh M.B. // Russ. Chem. Rev. 2008. V. 77 (5). P. 421-434.
  20. Agapkina Yu. Yu., Prikazchikova T. A., Smolov M.A., Gottikh M.B. // Uspekhi Biol. Khimii. V. 45. P. 87-122.
  21. Delelis O., Carayon K., Saïb A., Deprez E., Mouscadet J.-F. // Retrovirology. 2008. V. 5. P. 114.
  22. Poeschla E.M. // Cell Mol. Life Sci. 2008. V. 65. № 9. P. 1403-1424.
  23. Zheng R., Jenkins T.M., Craigie R. // Proc. Natl. Acad. Sci. USA. 1996. V. 93. № 24. P 13659-13664.
  24. Gallay P., Hope T., Chin D., Trono D. // Proc. Natl. Acad. Sci. USA. 2005. V. 94. P. 9825-9830.
  25. Podtelezhnikov A.A., Gao K., Bushman F.D., McCammon J.A. // Biopolymers. 2003. V. 68. № 1. P 110-120.
  26. Wielens J., Crosby I.T., Chalmers D.K. // J. Comput. Aided Mol. Des. 2005. V. 19. № 5. P 301-317.
  27. Ren G., Gao K., Bushman F.D., Yeager M. // J. Mol. Biol. 2007. V. 366. № 1. P. 286-294.
  28. Hare S., Gupta S.S., Valkov E., Engelman A., Cherepanov P // Nature. 2010. V. 464. № 7286. P 232-236.
  29. Delelis O., Carayon K., Guiot E., Leh H., Tauc P., Brochon J.C., Mouscadet J.-F., Deprez E. // J. Biol. Chem. 2008. V. 283. № 41. P. 27838-27849.
  30. Knyazhanskaya E.S., Smolov M.A., Kondrashina O.V., Gottikh M.B. // Acta Naturae. 2009. V. 1. № 2. P. 78-80.
  31. Sinha S., Pursley M.H., Grandgenett D.P // J. Virol. 2002. V. 76. P. 3105-3113.
  32. van Maele B., Debyser Z. // AIDS Rev. 2005. V. 7. P 26-43.
  33. Yu F., Jones G.S., Hung M., Wagner A.H., MacArthur H.L., Liu X., Leavitt S., McDermott M.J., Tsiang M. // Biochemistry. 2007. V. 46. № 10. P 2899-2908.
  34. Hazuda D.J., Felock P., Witmer M., Wolfe A., Stillmock K., Grobler J.A., Espeseth A., Gabryelski L., Schleif W., Blau C., et al. // Science. 2000. V. 287. № 5453. P. 646-650.
  35. Hazuda D.J., Anthony N.J., Gomez R.P., Jolly S.M., Wai J.S., Zhuang L., Fisher T.E., Embrey M., Guare J.P. Jr., Egbertson M.S., et al. // Proc. Natl. Acad. Sci. USA. 2004. V. 101. № 31. P. 11233-11238.
  36. Summa V., Petrocchi A., Matassa V.G., Gardelli C., Muraglia E., Rowley M., Paz O.G., Laufer R., Monteagudo E., Pace P. // J. Med. Chem. 2006. V. 49. № 23. P. 6646-6649.
  37. Guare J.P., Wai J.S., Gomez R.P., Anthony N.J., Jolly S.M., Cortes A.R., Vacca J.P., Felock P. J., Stillmock K.A., Schleif W.A., et al. // Bioorg. Med. Chem. Lett. 2006. V. 16. № 11. P. 2900-2904.
  38. Espeseth A.S., Felock P., Wolfe A., Witmer M., Grobler J., Anthony N., Egbertson M., Melamed J.Y., Young S., Hamill Т., et al. // Proc. Natl. Acad. Sci. USA. 2000. V. 97. № 21. P. 11244-11249.
  39. Goldgur Y., Craigie R., Cohen G.H., Fujiwara Т., Yoshinaga Т., Fujishita Т., Sugimoto H., Endo Т., Murai H., Davies D.R. // Proc. Natl. Acad. Sci. USA. 1999. V. 96. № 23. P. 13040-13043.
  40. Grobler J.A., Stillmock K., Hu B., Witmer M., Felock P., Espeseth A.S., Wolfe A., Egbertson M., Bourgeois M., Jeffrey Melamed J., et al. // Proc. Natl. Acad. Sci. USA. 2002. V. 99. № 10. P. 6661-6666.
  41. Marchand C., Zhang X., Pais G.C.G., Cowansage K., Neamati N., Burke T.R., Pommier Y. // J. Biol. Chem. 2002. V. 277. P. 12596-12603.
  42. Billich A. // Curr. Opin. Investig. Drugs. 2003. V. 4. № 2. P. 206-209.
  43. Zhuang L., Wai J.S., Embrey M.W., Fisher T.E., Egbertson M.S., Payne L.S., Guare J.P. Jr., Vacca J.P., Hazuda D.J., Felock P.J., et al. // J. Med. Chem. 2003. V. 46. № 4. P. 453-456.
  44. Cotelle P. // Recent Patents on Anti-Infective Drug Discovery. 2006. V. 1. P. 1-15.
  45. Petrocchi A., Koch U., Matassa V.G., Pacini B., Stillmock K.A., Summa V. // Bioorg. Med. Chem. Lett. 2007. V. 17. № 2. P. 350-353.
  46. Pace P., Di Francesco M.E., Gardelli C., Harper S., Muraglia E., Nizi E., Orvieto F., Petrocchi A., Poma M., Rowley M., et al. // J. Med. Chem. 2007. V. 50. № 9. P. 2225-2239.
  47. Gardelli C., Nizi E., Muraglia E., Crescenzi B., Ferrara M., Orvieto F., Pace P., Pescatore G., Poma M., Ferreira Mdel R., et al. // J. Med. Chem. 2007. V. 50. № 20. P. 4953-4975.
  48. Summa V., Petrocchi A., Bonelli F., Crescenzi B., Donghi M., Ferrara M., Fiore F., Gardelli C., Gonzalez Paz O., Hazuda D.J., et al. // J. Med. Chem. 2008. V. 51. № 18. P. 5843-5855.
  49. Kassahun K., McIntosh I., Cui D., Hreniuk D., Merschman S., Lasseter K., Azrolan N., Iwamoto M., Wagner J.A., Wenning L.A. // Drug. Metab. Dispos. 2007. V. 35. № 9. P. 1657-1663.
  50. Iwamoto M., Wenning L.A., Petry A.S., Laethem M., De Smet M., Kost J.T., Merschman S.A., Strohmaier K.M., Ramael S., Lasseter K.C., et al. // Clin. Pharmacol. Ther. 2008. V. 83. № 2. P. 293-299.
  51. Markowitz M., Morales-Ramirez J.O., Nguyen B.Y., Kovacs C.M., Steigbigel R.T., Cooper D.A., Liporace R., Schwartz R., Isaacs R., Gilde L.R., et al. // J. Acquir. Immune. Defic. Syndr. 2006. V. 43. № 5. P. 509-515.
  52. Schafer J.J., Squires K.E. // Ann. Pharmacother. 2010. V. 44. № 1. P. 145-156.
  53. Ménard A., Solas C., Mokthari S., Bregigeon S., Drogoul M.P., Tamalet C., Lacarelle B., Martin I.P. // AIDS. 2009. V. 23. № 7. P. 869-871.
  54. Grinsztejn B., Nguyen B.Y., Katlama C., Gatell J.M., Lazzarin A., Vittecoq D., Gonzalez C.J., Chen J., Harvey C.M., Isaacs R.D. // Lancet. 2007. V. 369. № 9569. P. 1261-1269.
  55. Steigbigel R.T., Cooper D.A., Teppler H., Eron J. J., Gatell J.M., Kumar P.N., Rockstroh J.K., Schechter M., Katlama C., Markowitz M., et al. // Clin. Infect. Dis. 2010. V. 50. № 4. P. 605-612.
  56. Markowitz M., Nguyen B.Y., Gotuzzo E., Mendo F., Ratanasuwan W., Kovacs C., Prada G., Morales-Ramirez J.O., Crumpacker C.S., Isaacs R.D., et al. // J. Acquir. Immune. Defic. Syndr. 2007. V. 46. № 2. P. 125-133.
  57. Lennox J.L., DeJesus E., Lazzarin A., Pollard R.B., Madruga J.V., Berger D.S., Zhao J., Xu X., Williams-Diaz A., Rodgers A.J., et al. // Lancet. 2009. V. 374. № 9692. P. 796-806.
  58. Towner W., Klein D., Kerrigan H.L., Follansbee S., Yu K., Horberg M. // J. Acquir. Immune. Defic. Syndr. 2009. V. 51. № 4. P. 367-373.
  59. FDA notifications. Raltegravir indication extended for treatment-naive patients // AIDS Alert. 2009. V. 24. № 8. P. 93.
  60. Cooper D.A., Steigbigel R.T., Gatell J.M., Rockstroh J.K., Katlama C., Yeni P., Lazzarin A., Clotet B., Kumar P.N., Eron J.E., et al. // N. Engl. J. Med. 2008. V. 359. № 4. P. 355-365.
  61. Malet I., Delelis O., Valantin M.A., Montes B., Soulie C., Wirden M., Tchertanov L., Peytavin G., Reynes J., Mouscadet J.-F., et al. // Antimicrob. Agents. Chemother. 2008. V. 52. № 4. P. 1351-1358.
  62. Delelis O., Malet I., Na L., Tchertanov L., Calvez V., Marcelin A.G., Subra F., Deprez E., Mouscadet J.-F. // Nucleic. Acids Res. 2009. V. 37. № 4. P. 1193-1201.
  63. Wiscount C.M., Williams P.D., Tran L.O., Embrey M.W., Fisher T.E., Sherman V., Homnick C.F., Donnette Staas D., Lyle T.A., Wai J.S., et al. // Bioorg. Med. Chem. Lett. 2008. V. 18. № 16. P. 4581-4583.
  64. Di Francesco M.E., Pace P., Fiore F., Naimo F., Bonelli F., Rowley M., Summa V. // Bioorg. Med. Chem. Lett. 2008. V. 18. № 8. P. 2709-2713.
  65. Wai J.S., Kim B., Fisher T.E., Zhuang L., Embrey M.W., Williams P.D., Staas D.D., Culberson C., Lyle T.A., Vacca J.P., et al. // Bioorg. Med. Chem. Lett. 2007. V. 17. № 20. P. 5595-5599.
  66. Muraglia E., Kinzel O., Gardelli C., Crescenzi B., Donghi M., Ferrara M., Nizi E., Orvieto F., Pescatore G., Laufer R., et al. // J. Med. Chem. 2008. V. 51. № 4. P. 861-874.
  67. Jin H., Wright M., Pastor R., Mish M., Metobo S., Jabri S., Lansdown R., Cai R., Pyun P., Tsiang M., et al. // Bioorg. Med. Chem. Lett. 2008. V. 18. № 4. P. 1388-1391.
  68. Garvey E.P., Johns B.A., Gartland M.J., Foster S.A., Miller W.H., Ferris R.G., Hazen R.J., Underwood M.R., Boros E.E., Thompson J.B., et al. // Antimicrob. Agents Chemother. 2008. V. 52. № 3. P. 901-908.
  69. Reddy Y.S., Min S.S., Borland J., Song I., Lin J., Palleja S., Symonds W.T. // Antimicrob. Agents Chemother. 2007. V. 51. № 12. P. 4284-4289.
  70. Min S., Song I., Borland J., Chen S., Lou Y., Fujiwara Т., Piscitelli S.C. // Antimicrob. Agents Chemother. 2010. V. 54. № 1. P. 254-258.
  71. Vandeckerckhove L. // Curr. Opin. Invest. Drugs. 2010. V. 11. P. 203-212.
  72. Sato M., Motomura Т., Aramaki H., Matsuda Т., Yamashita M., Ito Y., Kawakami H., Matsuzaki Y., Watanabe W., Yamataka K., et al. // J. Med. Chem. 2006. V. 49. № 5. P. 1506-1508.
  73. Sato M., Kawakami H., Motomura Т., Aramaki H., Matsuda T., Yamashita M., Ito Y., Matsuzaki Y., Yamataka K., Ikeda S., et al. // J. Med. Chem. 2009. V. 52. № 15. P. 4869-4882.
  74. Correll Т., Klibanov O.M. // Pharmacotherapy. 2008. V. 28. № 1. P. 90-101.
  75. DeJesus E., Berger D., Markowitz M., Cohen C., Hawkins Т., Ruane P., Elion R., Farthing C., Zhong L., Cheng A.K., et al. // J. Acquir. Immune. Defic. Syndr. 2006. V. 43. № 1. P. 1-5.
  76. Zolopa A.R., Berger D.S., Lampiris H., Zhong L., Chuck S.L., Enejosa J.V., Kearney B.P., Cheng A.K. // J. Infect. Dis. 2010. V. 201. № 6. P. 814-822.
  77. Cohen C., Elion R., Ruane P., Shamblaw D., DeJesus E., Rashbaum B., Chuck S.L., Yale K., Liu H.C., Warren D.R., et al. // AIDS. 2011. V. 25. № 6. P. F7-F12.
  78. McColl D.J., Fransen S., Gupta S., Parkin N., Margot N., Chuck S., Cheng A.K., Miller M.D. // Antivir. Ther. 2007. V. 12. P. S11-S111.
  79. Ceccherini-Silberstein F., Malet I., D’Arrigo R., Antinori A., Marcelin A.G., Perno C.F. // AIDS Rev. 2009. V. 11. № 1. P. 17-29.
  80. Goethals O., Clayton R., van Ginderen M., Vereycken I., Wagemans E., Geluykens P., Dockx K., Strijbos R., Smits V., Vos A., et al. // J. Virol. 2008. V. 82. № 21. P. 10366-10374.
  81. Langley D.R., Samanta H.K., Lin Z., Walker M.A., Krystal M.R., Dicker I.B. // Biochemistry. 2008. V. 47. P. 13481-13488.
  82. Marinello J., Marchand C., Mott B.T., Bain A., Thomas C.J., Pommier Y. // Biochemistry. 2008. V. 47. № 36. P. 9345-9354.
  83. Kobayashi M., Nakahara K., Seki Т., Miki S., Kawauchi S., Suyama A., Wakasa-Morimoto C., Kodama M., Endoh Т., Oosugi E., et al. // Antiviral Res. 2008. V. 80. № 2. P. 213-222.
  84. Nakahara K., Wakasa-Morimoto C., Kobayashi M., Miki S., Noshi Т., Seki Т., Kanamori-Koyama M., Kawauchi S., Suyama A., Fujishita Т., et al. // Antiviral Res. 2009. V. 81. № 2. P. 141-146.
  85. an Baelen K., van Eygen V., Rondelez E., Stuyver L.J. // AIDS. 2008. V. 22. P. 1877-1880.
  86. Bar-Magen Т., Donahue D.A., McDonough E.I. // AIDS. 2010. V. 24. № 14. P. 2171-2179.
  87. Maiga A.I., Malet I., Soulie C., Derache A., Koita V., Amellal B., Tchertanov L., Delelis O., Morand-Joubert L., Mouscadet J.-F., et al. // Antivir. Ther. 2009. V. 14. P. 123-129.
  88. Sichtig N., Sierra S., Kaiser R., Daumer M., Reuter S., Schulter E., Altmann A., Fatkenheuer G., Dittmer U., Pfister H., et al. // J. Antimicrob. Chemother. 2009. V. 64. P. 25-32.
  89. Mekouar K., Mouscadet J.-F., Desmaёle D., Subra F., Leh H., Savoure D., Auclair C., d’Angelo J. // J. Med. Chem. 1998. V. 41. P. 2846-2857.
  90. Ouali M., Laboulais C., Leh H., Gill D., Desmaele D., Mekouar K., Zouhiri F., d’Angelo J., Auclair C., Mouscadet J.-F., et al. // J. Med. Chem. 2000. V. 43. № 10. P. 1949-1957.
  91. Zouhiri F., Mouscadet J.-F., Khalid Mekouar K., Desmaёle D., Savouré D., Leh H., Subra F., Le Bret M., Auclair C., d’Angelo J. // J. Med. Chem. 2000. V. 43. P. 1533-1540.
  92. Deprez E., Barbe S., Kolaski M., Leh H., Zouhiri F., Auclair C., Brochon J.-C., Le Bret M., Mouscadet J.-F. // Mol. Pharmacol. 2004. V. 65. № 1. P. 85-98.
  93. Pannecouque C., Pluymers W., van Maele B., Tetz V., Cherepanov P., De Clercq E., Witvrouw M., Debyser Z. // Curr. Biol. 2002. V. 12. № 14. P. 1169-1177.
  94. Hombrouck A., Hantson A., van Remoortel B., Michiels M., Vercammen J., Rhodes D., Tetz V., Engelborghs Y., Christ F., Debyser Z., et al. // J. Antimicrob. Chemother. 2007. V. 59. № 6. P. 1084-1095.
  95. Al-Mawsawi L.Q., Neamati N. // Trends Pharmacol. Sci. 2007. V. 28. № 10. P. 526-535.
  96. Mazumder A., Wang S., Neamati N., Nicklaus M., Sunder S., Chen J., Milne G.W.A., Rice W.G., Burke T.R. Jr., Pommier Y. // J. Med. Chem. 1996. V. 39. P. 2472-2481.
  97. Al-Mawsawi L.Q., Fikkert V., Dayam R., Witvrouw M., Burke T.R. Jr., Borchers C.H., Neamati N. // Proc. Natl. Acad. Sci. USA. 2006. V. 103. № 26. P. 10080-10085.
  98. De Luca L., Barreca M.L., Ferro S., Christ F., Iraci N., Gitto R., Monforte A.M., Debyser Z., Chimirri A. // Chem. Med. Chem. 2009. V. 4. № 8. P. 1311-1316.
  99. Al-Mawsawi L.Q., Christ F., Dayam R., Debyser Z., Neamati N. // FEBS Lett. 2008. V. 582. № 10. P. 1425-1430.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Korolev S.P., Agapkina Y.Y., Gottikh M.B., 2011

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution 4.0 International License.

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах